Updated Jul 16, 2026
Roman Shawn David has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Shawn David Roman is the Chief Operating Officer of Apyx Medical Corp (APYX), a medical device company focused on energy-based cosmetic and surgical technologies, including Renuvion. The SEC filing context provided lists him as COO with no reported purchases or sales and only a single filing as of January 29, 2026, indicating his role as a corporate insider for APYX. Public information beyond the SEC filing is limited in the provided context.
| Role | Chief Operating Officer |
|---|---|
| Notability | 42/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-17 | APYX | Apyx Medical Corp | F — Tax withholding / forfeiture | 10.5K | $4.60 | $48K |
| 2026-06-17 | APYX | Apyx Medical Corp | M — Option exercise | 15.0K | $3.23 | $48K |
| 2026-01-29 | APYX | Apyx Medical Corp | M — Option exercise | 12.0K | $1.80 | $22K |
Shawn David Roman is the Chief Operating Officer of Apyx Medical Corp (APYX), a medical device company focused on energy-based cosmetic and surgical technologies, including Renuvion. The SEC filing context provided lists him as COO with no reported purchases or sales and only a single filing as of January 29, 2026, indicating his role as a corporate insider for APYX. Public inf…
2 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Roman Shawn David profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.